Gabapentin can produce a high, though the effect is inconsistent and depends heavily on dose, individual biology, and whether other substances are involved. People who misuse it report euphoria, deep sedation, and altered sociability at doses far above what doctors typically prescribe, sometimes ranging from 1,500 mg to 12,000 mg in a single session. The drug was long considered to have essentially zero abuse potential, but that reputation has eroded significantly over the past decade as misuse reports have climbed, particularly among people with opioid use disorders. The risks go well beyond a rough morning after: combining gabapentin with opioids or other depressants can be fatal.
What the Gabapentin High Feels Like
The psychoactive effects people chase with gabapentin are surprisingly varied. A systematic review of misuse reports found that euphoria was among the most commonly described sensations, with users comparing it to a milder version of an opioid high. That euphoria showed up both when gabapentin was taken alongside other drugs and when it was taken on its own, at doses ranging from roughly 1,500 to 12,000 mg. But euphoria is only part of the picture. Sedation, relaxation, and a feeling of deep calm were reported nearly as often. Some users described improved sociability, increased energy, or a marijuana-like mellowness. Others reported more intense experiences: a cocaine-like rush, an “amphetamine” feeling, or effects resembling MDMA. One case study even documented people snorting gabapentin powder from capsules to get a stimulant-like hit.1PubMed Central. Gabapentin misuse, abuse, and diversion: A systematic review
The range of reported effects is unusually broad for a single drug. Part of this likely comes from the different doses people use, what they combine it with, and their own neurochemistry. Someone taking gabapentin with buprenorphine or methadone is going to have a very different experience than someone swallowing a handful of capsules on an empty stomach. The common thread is that gabapentin, at high enough doses, clearly does something noticeable to mood and consciousness. Calling it a “non-addictive” medication, as many prescribers still do, misses this reality.
Why Gabapentin Was Considered Safe from Abuse
Gabapentin was designed as an anticonvulsant, and its mechanism of action looks nothing like the classic drugs of abuse. It binds to a specific part of voltage-gated calcium channels in the brain, but it doesn’t directly boost dopamine the way opioids, stimulants, or alcohol do.2PubMed Central. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin When gabapentin was first characterized pharmacologically, researchers noted it was the first drug known to interact with that particular calcium channel subunit, and its effects on calcium currents themselves were minimal or absent.3Journal of Biological Chemistry. The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel In plain terms, the drug reduces excitatory signaling in the nervous system without acting on the brain’s main reward circuits in any obvious way.
This clean-looking mechanism led regulators and clinicians to treat gabapentin as essentially non-abusable. It was never federally scheduled as a controlled substance in the United States, and for years prescribers handed it out freely for pain, anxiety, insomnia, and a long list of off-label conditions. That permissiveness created enormous availability: between 2011 and 2016, less than one percent of gabapentin prescriptions in outpatient settings were for an FDA-approved indication.4PubMed. Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016 The drug was everywhere, cheap, and perceived as harmless. That combination made it an easy target for misuse.
The Absorption Ceiling and How People Get Around It
One pharmacological quirk of gabapentin is that your gut can only absorb so much of it at once. The drug relies on a specific transport system in the intestine to get into the bloodstream, and that system has a ceiling. Studies of gabapentin absorption show dose-dependent oral absorption kinetics: the more you take in a single dose, the smaller the percentage your body actually absorbs.5PubMed. In vivo and in vitro evaluations of intestinal gabapentin absorption: effect of dose and inhibitors on carrier-mediated transport At standard therapeutic doses of 300 to 600 mg, bioavailability is reasonable. At 3,600 mg or higher, a significant chunk passes right through you.
People who misuse gabapentin have figured this out empirically. Rather than taking a massive dose all at once, many stagger their intake, swallowing a few hundred milligrams every 30 to 60 minutes over several hours to keep the transport system working near capacity. Others take it with fatty food, which appears to increase absorption. Some bypass the gut entirely by snorting the powder from opened capsules. These workarounds help explain why the doses reported in misuse cases often sound absurdly high: much of that oral dose never reaches the brain.
Who Is Most Likely to Misuse Gabapentin
Gabapentin misuse is not evenly distributed across the population. It clusters overwhelmingly among people with existing substance use disorders, especially opioid addiction. One study found that 26 percent of patients with an opioid use disorder reported illegally obtaining, overusing, or faking symptoms to get gabapentin, compared to just 4 percent of patients without an opioid use disorder.6PubMed. Abuse of Gabapentin is Associated with Opioid Addiction That difference is stark enough that the researchers described gabapentin abuse as largely specific to the opioid-addicted population.
A broader estimate puts gabapentinoid misuse at roughly 1.6 percent in the general population, but prevalence among people who misuse opioids ranges from 3 to 68 percent depending on the study and setting.7PubMed. Abuse and Misuse of Pregabalin and Gabapentin Research on people starting buprenorphine treatment for opioid addiction found that all types of co-occurring substance use disorders were associated with increased gabapentin receipt, with sedative use disorder being the strongest predictor.8JAMA Psychiatry. Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder In South Florida, a study of people who misuse opioids found that 43 percent had misused gabapentin without ever receiving a prescription for it, and 14 percent had started misusing it before ever being prescribed the drug.9PubMed Central. Descriptions of Gabapentin Misuse and Associated Behaviors among a Sample of Opioid (Mis)users in South Florida
The pattern is clear: gabapentin misuse is primarily a problem layered on top of other substance use, not typically a standalone addiction in people with no history of drug problems. This matters for clinicians, because prescribing gabapentin to someone already struggling with opioid or sedative use carries a meaningfully different risk profile than prescribing it to someone with no such history.
The Opioid Combination Problem
The most dangerous aspect of gabapentin misuse is not the drug itself taken alone. It is what happens when gabapentin is combined with opioids or other central nervous system depressants. A large population-based study found that people co-prescribed gabapentin and opioids had roughly 49 percent higher odds of opioid-related death compared to those prescribed opioids alone, after adjusting for other risk factors. At moderate and high gabapentin doses, the increase was closer to 60 percent.10PubMed Central. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
A separate study in Medicare recipients found that people using gabapentin alongside high-dose opioids had more than double the risk of dying from any cause compared to people using duloxetine (an antidepressant sometimes used for pain) with the same opioid doses.11PubMed Central. Concurrent Gabapentin and Opioid Use and Risk of Mortality in Medicare Recipients with Non-Cancer Pain The suspected mechanism involves respiratory depression: gabapentin appears to amplify the way opioids suppress breathing, which is the primary way opioid overdoses kill people.12The Lancet Regional Health – Americas. Utilization of gabapentin, opioids, and benzodiazepines and associated public health outcomes among Medicare disabled beneficiaries: A nested case-control study Adding benzodiazepines to the mix makes things worse still, creating a triple-threat of respiratory suppression. Surgical patients given gabapentinoids alongside opioids for post-operative pain have also shown increased rates of central nervous system and respiratory depression.13JAMA Network Open. Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
An analysis of FDA adverse event reports found that gabapentin was associated with significantly elevated odds of drug withdrawal syndrome, euphoric mood, hallucinations, delusions, and ataxia compared to a reference drug. The odds of euphoric mood reports were more than five times higher for gabapentin, and drug withdrawal syndrome was more than six times higher.14PubMed Central. Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system These are safety signals, not proof of causation, but they reinforce the picture of a drug that has real psychoactive punch and real dependence potential when used outside its intended parameters.
What Happens in a Gabapentin-Only Overdose
If gabapentin’s combination risks sound alarming, the drug’s solo overdose profile is, perhaps surprisingly, relatively forgiving. A poison center case series examined 20 overdoses where gabapentin was the only substance ingested, at doses ranging from 50 mg all the way up to 35,000 mg. Clinical effects appeared early and resolved within about 10 hours in most patients. The most common symptoms were drowsiness, dizziness, nausea, and in a couple of cases, low blood pressure or a fast heart rate. None of the patients needed hospital admission.15PubMed. Characterization of gabapentin overdose using a poison center case series
The absorption ceiling mentioned earlier helps explain this. Even at enormous oral doses, the intestinal transport system limits how much gabapentin actually enters the bloodstream. That built-in safety margin does not apply to people with kidney problems, however. Gabapentin is cleared almost entirely by the kidneys, and people with impaired kidney function can develop serious toxicity even at normal prescribed doses. A case report described a woman on dialysis who became severely drowsy and progressively lost consciousness after a single standard dose. Dialysis cleared the drug and she recovered quickly, but the episode illustrates how kidney function changes the risk calculation entirely.16PubMed Central. Gabapentin toxicity: an important cause of altered consciousness in patients with uraemia
Dependence and Withdrawal
Regular gabapentin use, especially at high doses, can produce physical dependence. This is true even in people taking it as prescribed, though the risk is higher with misuse. Researchers have drawn parallels to benzodiazepines, noting that gabapentinoids share some of the same issues with tolerance, dependence, and withdrawal.17PubMed. Should gabapentinoids be prescribed long-term for anxiety and other mental health conditions? Multiple case reports have documented gabapentin dependence and withdrawal in clinical settings.18PubMed. Gabapentin: Abuse, Dependence, and Withdrawal
Withdrawal symptoms typically include anxiety, sweating, and palpitations, but more severe presentations have been documented. One case reported a patient who developed status epilepticus, a dangerous form of continuous seizure activity, after abruptly stopping gabapentin.19PubMed. Gabapentin withdrawal presenting as status epilepticus Another described a hospitalized patient who developed restlessness, confusion, agitation, and light sensitivity within days of gabapentin being discontinued; restarting the drug improved her symptoms the same evening.20American Journal of Health-System Pharmacy. Withdrawal symptoms after gabapentin discontinuation
For people who have become heavily dependent, tapering off gabapentin can be a long process. One case report described a patient with alcohol use disorder whose gabapentin taper took 18 months. The process started with dose reductions of about 100 mg per month, slowed to 20 to 30 mg per month as the dose got lower, and eventually required 5 mg decrements every one to two weeks near the end.21PubMed. Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report This is an extreme case, but it gives a sense of how entrenched gabapentin dependence can become. The takeaway for anyone using gabapentin regularly is straightforward: do not stop abruptly without medical guidance.
Why Standard Drug Tests Miss It
Gabapentin does not show up on the standard urine drug screens used in most hospital emergency departments and workplace drug testing programs. These panels typically screen for 7 to 9 drug classes using immunoassay technology, and gabapentin is not among them.22PubMed Central. Gabapentin prevalence: clinical and forensic experience in St. Louis, Missouri, USA Detecting gabapentin requires a specific request for additional testing, usually through gas chromatography or mass spectrometry, which costs more and takes longer. This blind spot has consequences in two directions. For clinicians trying to identify gabapentin misuse in patients, the standard screen offers no help. For people misusing gabapentin to get high, the drug’s invisibility on common tests is part of the appeal, especially for those on probation, parole, or in treatment programs that rely on urine screens to verify abstinence from other substances.
The Shifting Regulatory Landscape
Gabapentin remains unscheduled at the federal level in the United States, but states have been moving independently. By 2024, 25 U.S. jurisdictions, about half, had enacted some form of policy around gabapentin. Eight of those classified it as a Schedule V controlled substance (the lowest tier, alongside drugs like cough syrups containing small amounts of codeine) and required that gabapentin prescriptions be logged in the state’s prescription drug monitoring program. Seventeen additional jurisdictions required monitoring without formally scheduling the drug.23PubMed Central. A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016-2024
West Virginia was one of the earliest states to schedule gabapentin, and researchers have studied whether that move affected overdose rates.24PubMed Central. Impact of schedule V controlled substance classification of gabapentin on adult gabapentin-involved overdose rates, West Virginia, 2016-2019: A controlled time series analysis The patchwork nature of state-level regulation creates complications: a drug that requires monitoring in one state may be prescribed freely across the border. And scheduling can have unintended consequences for patients who genuinely benefit from gabapentin for seizures or nerve pain, adding paperwork, limiting refill flexibility, and sometimes creating stigma.
Off-Label Prescribing and the Supply Problem
A major contributor to gabapentin’s availability for misuse is the sheer volume prescribed for conditions where its evidence base is thin. Gabapentin is widely used for anxiety, insomnia, bipolar disorder, and various pain conditions, frequently as an alternative to opioids.25PubMed Central. Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern? The irony is not lost on researchers: gabapentin’s rise was fueled in part by the desire to reduce opioid prescribing, but it introduced its own set of misuse problems, and it turns out to be most dangerous precisely when combined with the opioids it was supposed to replace.
The volume of off-label prescribing is staggering. Survey data from 2011 to 2016 found gabapentin listed on about 2.8 percent of all outpatient visits, representing an estimated 130 million visits over that period. Less than one percent of those visits listed an FDA-approved indication like epilepsy or postherpetic neuralgia.4PubMed. Outpatient Off-Label Gabapentin Use for Psychiatric Indications Among U.S. Adults, 2011-2016 Off-label prescribing is not inherently wrong, but it does create a vast supply of gabapentin circulating in medicine cabinets, available for diversion or misuse. The South Florida study mentioned earlier found that a large portion of people misusing gabapentin had never been prescribed it themselves, obtaining it through friends, family, or street purchase.
How Gabapentin Compares to Pregabalin
Pregabalin, sold as Lyrica, is gabapentin’s close chemical cousin. Both drugs bind to the same calcium channel subunit and have similar therapeutic uses. But pregabalin is absorbed more completely and more predictably than gabapentin because it does not rely on the same saturable intestinal transport system. This means pregabalin’s effects kick in faster and scale more reliably with dose, both of which make a drug more attractive for recreational use. Pregabalin is already classified as a Schedule V controlled substance at the federal level, a recognition of its higher abuse potential that gabapentin has so far avoided federally. Updated systematic reviews continue to confirm that both drugs are misused in similar populations and contexts, often alongside opioids, and that concomitant use with opioids or benzodiazepines increases overdose risks for both.26Springer Link / Drugs. Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update
Practical Harm Reduction
If you take gabapentin as prescribed for a legitimate medical condition, none of this means you need to panic. At standard doses for seizure control or nerve pain, the drug has a long track record and a genuine role in treatment. The risks escalate with dose, with co-ingestion of other depressants, and with a personal history of substance use disorders. A few things are worth keeping in mind.
Combining gabapentin with opioids, benzodiazepines, or alcohol is where the serious danger lies. If you are prescribed gabapentin and also take any of these substances, your prescriber should know about all of them. The respiratory depression risk from combinations is not theoretical; it shows up consistently across large studies and in coroners’ reports.
Stopping gabapentin abruptly after regular use is risky. Even if you have been taking it as prescribed, sudden discontinuation can provoke withdrawal symptoms ranging from anxiety and insomnia to, in rare cases, seizures. Any dose reduction should be gradual and supervised. If you have been taking doses well above what was prescribed, the taper may need to be especially slow.
Standard drug tests will not catch gabapentin. If you are a clinician screening patients for substance misuse, or a patient trying to be transparent about your drug use in a treatment setting, be aware that gabapentin will not appear on a routine urine panel. Specific testing has to be requested. This gap in standard screening has made gabapentin a drug of choice for people trying to get high while passing drug tests, and it means clinicians need to maintain a higher index of suspicion than the screen alone provides.